Natera has released new data from the GALAXY arm of its ongoing CIRCULATE-Japan trial showing the efficacy of its molecular ...

To combat counterfeit semiconductors, researchers at Purdue University’s College of Engineering have developed an optical ...

Adela’s tissue-agnostic MRD test has been clinically validated to predict and surveil for recurrence in patients with head & ...

BOULDER, Colo., Sept. 10, 2024 (GLOBE NEWSWIRE) -- (Foresight), a leader in ultra-sensitive minimal residual disease (MRD) detection, today announced an upcoming presentation featuring its Foresight ...

Certain genetic changes, or mutations, can increase the chances of leukemia or blood cancer. According to experts, leukemia, ...

Purdue University researchers have developed RAPTOR, an optical counterfeit detection method for chips used in semiconductor devices.

Drs Kathy D. Miller and Heather A. Parsons explore the complexities and evolving strategies in managing HER2+ oligometastatic ...

This data provides the first evidence of Signatera-based molecular residual disease (MRD) detection to predict overall survival (OS) and highlights Signatera’s ability to predict adjuvant chemotherapy ...

Reid W. Merryman, MD, discussed the latest developments with minimal residual disease assays in the management of patients ...

Donor lymphocyte infusion, both alone and in combination with azacitidine, restored CD34 levels in two-thirds of patients ...